LYNNEA MARIE SKIMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FLAT ROCK, NC NPI 1205571007
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NC BeiGene USA, Inc. All categories
General Payments — all program years on this page
$2,699.01
- Category: General Payments
- Program years: PY2021–2024
- Record count: 49
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,027.94 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,395.35 | 38 |
| Consulting Fee | $600.00 | 2 |
| Education | $32.59 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $600.00 | 2 |
| Janssen Biotech, Inc. | $384.26 | 4 |
| Karyopharm Therapeutics Inc. | $179.45 | 3 |
| E.R. Squibb & Sons, L.L.C. | $150.31 | 3 |
| Genmab U.S., Inc. | $115.67 | 2 |
| SOBI, INC | $62.52 | 3 |
| ABBVIE INC. | $49.76 | 2 |
| Lilly USA, LLC | $44.62 | 2 |
| Celgene Corporation | $40.67 | 2 |
| Coherus Biosciences Inc. | $40.40 | 2 |
| Kyowa Kirin, Inc. | $38.01 | 2 |
| PFIZER INC. | $36.80 | 2 |
| Hologic Sales and Service, LLC | $36.54 | 1 |
| Pharmacosmos Therapeutics Inc. | $33.82 | 2 |
| Acerta Pharma LLC | $32.94 | 2 |
| Merck Sharp & Dohme Corporation | $31.76 | 1 |
| Tempus AI, Inc | $27.69 | 1 |
| Rigel Pharmaceuticals, Inc. | $27.45 | 1 |
| GlaxoSmithKline, LLC. | $25.57 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.52 | 1 |
| Astellas Pharma US Inc | $17.85 | 1 |
| Gilead Sciences, Inc. | $15.37 | 1 |
| Exelixis Inc. | $13.96 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.